Stocks · Health care · Pharmaceutical Preparations

Annexon, Inc.

ANNX Clue Score37

United States Fiscal year ends December CIK 0001528115 Results filed 12 Aug 2026

Add to watchlist

What the insiders did Net buying

By person

9 insiders · 24 transactions

Insider

Role

Bought

Sold

Net

Holding

Of company

Worth

Change

Muneer A Satter

Director

$11.97M (6)

—

+$11.97M

10,342,134

6.92%

$39.61M

+39.6%

William H. Carson

Director

$180.25K (5)

—

+$180.25K

78,405

0.0525%

$300.29K

+250.0%

Jung Choi

Director

$138.27K (1)

—

+$138.27K

33,000

0.0221%

$126.39K

—

Douglas Love

President and CEO

$99.83K (1)

—

+$99.83K

390,476

0.2614%

$1.50M

+17.8%

Ted Yednock

EVP & Chief Innovation Officer

—

$70.32K (2)

−$70.32K

184,807

0.1237%

$707.81K

+58.9%

Jennifer Lew

EVP & Chief Financial Officer

—

$70.28K (2)

−$70.28K

170,700

0.1143%

$653.78K

+29.9%

Dean Richard Artis

EVP & Chief Scientific Officer

—

$58.98K (2)

−$58.98K

180,093

0.1206%

$689.76K

+34.1%

Jamie Dananberg

Chief Medical Officer

—

$58.58K (2)

−$58.58K

123,582

0.0827%

$473.32K

+47.2%

Michael Overdorf

EVP & Chief Business Officer

—

$55.26K (2)

−$55.26K

182,625

0.1223%

$699.45K

+30.8%